Ligand validation:5IWG

PG5: 1-METHOXY-2-[2-(2-METHOXY-ETHOXY]-ETHANE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5IWG_PG5_A_405	8%	90%	0.264	0.735	0.5	0.12	-	-	0	0	100%	1
5IX0_PG5_B_409	20%	83%	0.186	0.788	0.5	0.29	-	-	0	0	100%	1
3MR0_PG5_B_143	100%	88%	0.02	0.995	0.43	0.25	-	-	2	0	100%	1
4IQF_PG5_A_401	86%	43%	0.072	0.971	0.67	1.52	-	-	0	0	83%	0.8333
3RIH_PG5_A_273	72%	83%	0.116	0.939	0.46	0.33	-	-	0	0	100%	1
3D01_PG5_J_166	69%	76%	0.106	0.921	0.47	0.49	-	-	1	0	100%	1
5AII_PG5_A_1130	60%	75%	0.091	0.876	0.58	0.39	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.